Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?


Hanquet, G; Perrocheau, A; Kissling, E; Bruhl, DL; Tarragó, D; Stuart, J; Stefanoff, P; Heuberger, S; Kriz, P; Vergison, A; de Greeff, SC; Amato-Gauci, A; Celentano, LP; ECDC Country Experts for Pneumococcal Disease, ; (2010) Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? Vaccine, 28 (23). pp. 3920-8. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.03.069

Full text not available from this repository.

Abstract

In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance. We confirmed the heterogeneity of surveillance systems and case definitions across countries but identified elements common to all countries, such as the availability of serotyping and the surveillance of pneumococcal meningitis. PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Vaccine Centre
PubMed ID: 20394721
Web of Science ID: 278985600008
URI: http://researchonline.lshtm.ac.uk/id/eprint/61405

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
279Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item